» Articles » PMID: 4270346

Effect of Immunosuppression on Chronic LCM Virus Infection of Mice

Overview
Journal J Exp Med
Date 1973 Oct 1
PMID 4270346
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

C3H mice chronically infected with LCM virus were found to be lethally affected by small doses of immunosuppression which caused bone marrow aplasia but had no effect on the amount of virus carried by the mouse. Humoral immune response of SWR/J mice to acute LCM infection was found to be totally suppressed by repeated single doses of 300 R/wk with no alteration in the level of virus carried by the mouse. In contrast, the established anti-LCM humoral immune response encountered in mice chronically infected with LCM virus was not suppressed by the same irradiation procedure. Over half of the chronic LCM carrier SWR/J mice treated with cyclophosphamide for 6 mo had total anti-LCM humoral immunosuppression, but showed no change in the level of virus carried. The glomerulonephritis which occurs in chronic LCM carrier mice was prevented by cyclophosphamide treatment in 90% of the mice. The humoral immune response which occurs in chronic LCM carrier mice appears to play no role in controlling the amount of virus carried by the mouse. Suppression of the LCM immune response by cyclophosphamide does prevent the development of glomerulonephritis in these mice.

Citing Articles

Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons.

Truong P, Heydari S, Garidou L, McGavern D J Immunol. 2009; 183(6):3895-905.

PMID: 19717517 PMC: 5001847. DOI: 10.4049/jimmunol.0803085.


Viral infections, their influence on some parts of the immune system and glomerulonephritis development.

Steciwko A Int Urol Nephrol. 1987; 19(4):433-9.

PMID: 3323103 DOI: 10.1007/BF02550362.


Response of sublethally irradiated monkeys to a replicating viral antigen.

Hilmas D, SPERTZEL R Infect Immun. 1975; 12(3):592-601.

PMID: 809358 PMC: 415328. DOI: 10.1128/iai.12.3.592-601.1975.


Increased survival times of New Zealand hybrid mice immunosuppressed by graft-versus-host reactions.

Lehman D, Wilson C, Dixon F Clin Exp Immunol. 1976; 25(2):297-302.

PMID: 8228 PMC: 1541357.

References
1.
HOLLAND N, Bennett N . Hypocomplementemic (membranoproliferative) glomerulonephritis. Immunosuppressive therapy. Am J Dis Child. 1972; 123(5):439-45. DOI: 10.1001/archpedi.1972.02110110067001. View

2.
Cameron J . Bright's disease today: the pathogenesis and treatment of glomerulonephritis. II. Br Med J. 1972; 4(5833):160-3 contd. PMC: 1786377. DOI: 10.1136/bmj.4.5833.160. View

3.
Ahlmen J, Attman P, Bengtsson Y . Experience of immunosuppressive therapy of glomerular disease in adults. Acta Med Scand. 1971; 190(5):425-8. DOI: 10.1111/j.0954-6820.1971.tb07453.x. View

4.
Volkert M . Haemopoietic defects in mice infected with lymphocytic choriomeningitis virus. 2. The viral effect upon the function of colony-forming stem cells. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972; 80(6):853-62. View

5.
Urizar R, Tinglof B, McIntosh R, LITMAN N, Barnett E, Wilkerson J . Immunosuppressive therapy of proliferative glomerulonephritis in children. Am J Dis Child. 1969; 118(3):411-25. DOI: 10.1001/archpedi.1969.02100040413001. View